Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial. - Galsky, Matthew D; Arija, José Ángel Arranz; Bamias, Aristotelis; Davis, Ian D; De Santis, Maria; Kikuchi, Eiji; Garcia-Del-Muro, Xavier; De Giorgi, Ugo; Mencinger, Marina; Izumi, Kouji; Panni, Stefano; Gumus, Mahmut; et al. (Lancet, 2020)